Reaction
Biopsy reporting signals
As of the last recalculation, Biopsy appears in 915 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is CHOLESTYRAMINE (PRR 19.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Cholestyramine | 10 | 19.0 | 19.0 |
| Tofacitinib Citrate | 9 | 15.8 | 15.8 |
| Voclosporin | 5 | 13.2 | 13.2 |
| Ibrutinib | 40 | 11.7 | 11.7 |
| Macitentan | 32 | 10.9 | 10.9 |
| Niraparib | 10 | 10.4 | 10.4 |
| Conjugated Estrogens And Medroxyprogesterone Acetate | 10 | 9.7 | 9.7 |
| Rucaparib | 3 | 7.8 | 7.8 |
| Relugolix | 7 | 6.8 | 6.8 |
| Avapritinib | 3 | 5.7 | 5.7 |